简单口服营养补充对胃癌术后患者体重丢失的疗效:多中心随机对照试验
这项多中心开放标签平行随机对照试验纳入124例胃癌根治性胃切除患者,比较术后8周每日400 mL(kcal)以碳水与蛋白质为主的简单口服营养补充(ONS)与常规护理。ONS组术后8周体重丢失百分比显著低于对照组(-4.8% vs -6.4%,P=0.039),握力与血液学参数无显著差异,不良事件发生率相当,但ONS组失眠、食欲丧失和腹泻症状评分更高。
要点
- 胃癌胃切除术后8周简单ONS可减少体重丢失(-4.8% vs -6.4%,P=0.039)。
- ONS对握力和血液学参数无显著改善。
- ONS组失眠、食欲丧失、腹泻症状评分更高,需关注耐受性。
核心结论
- 胃癌胃切除术后8周简单ONS可减少术后体重丢失。
研究设计与样本
- 多中心、开放标签、平行、随机对照试验,共19家机构参与。
- 124例胃癌根治性胃切除患者随机分为ONS组(n=62)和对照组(n=62),ONS组2例失访。
- ONS组术后8周内每日接受400 mL(kcal)以碳水化合物和蛋白质为主的简单ONS。
主要发现
- ONS组术后8周体重丢失百分比显著低于对照组(-4.8% vs -6.4%,P=0.039)。
- 握力和血液学参数两组无显著差异。
- 不良事件发生率两组相当(7% vs 11%,P=0.373)。
- ONS组干预期间失眠、食欲丧失和腹泻症状评分更高。
- 平均ONS摄入量>75%(308.7 mL±97.0 mL/d)。
临床怎么用
- 胃癌胃切除术后可考虑使用简单ONS 8周以减少体重丢失。
- 需监测ONS相关失眠、食欲丧失和腹泻症状。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the efficacy of a simple oral nutritional supplement (ONS) without excess nutrients on body weight loss (BWL) after gastrectomy in patients with gastric cancer. SUMMARY BACKGROUND DATA: BWL is commonly observed in the early few months after gastrectomy for gastric cancer. It is uncertain if a simple ONS with usual diet improve postoperative BWL. METHODS: A multicenter randomized controlled trial was conducted across 19 institutions. Patients undergoing curative gastrectomy for gastric cancer were randomized into the ONS or control group. The ONS group received 400 mL (kcal)/day of ONS mainly containing carbohydrates and proteins for 8 weeks postoperatively. The primary endpoint was the percentage of BWL from baseline to postoperative 8 weeks. Secondary endpoints included handgrip strength, hematological parameters, health-related quality of life, dietary intake, and ONS adherence. RESULTS: The 124 patients were randomized to the ONS group (n=62) or control group (n=62), with 2 in the ONS group lost to follow-up. The ONS group experienced significantly less weight loss at postoperative 8 weeks (-4.8% vs. -6.4%, P=0.039). No significant differences were observed in handgrip strength or hematological parameters. The incidences of adverse events were comparable between the groups (7% vs. 11%, P=0.373), but the ONS group had higher symptom scores for insomnia, appetite loss, and diarrhea during intervention. The mean ONS intake was >75% (308.7 mL±97.0 mL/d). CONCLUSIONS: The simple ONS for 8 weeks after gastrectomy reduced postoperative BWL in patients with gastric cancer.
引用
- Ueno K, Nishigori T, Tokoro Y, et al. Efficacy of Simple Oral Nutritional Supplements versus Usual Care in Postoperative Patients with Gastric Cancer: A Multicenter, Open-label, Parallel, Randomized Controlled Trial. Ann Surg. 2025. PMID: 40772645. doi:10.1097/SLA.0000000000006888
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。